Organic Cation Transporters in the Lung—Current and Emerging (Patho)Physiological and Pharmacological Concepts

Autor: Johannes A. Sake, Johanna J. Salomon, Carsten Ehrhardt, Mohammed Ali Selo
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Gene Expression
Endogeny
Review
Pharmacology
030226 pharmacology & pharmacy
lcsh:Chemistry
chemistry.chemical_compound
0302 clinical medicine
drug uptake
Homeostasis
Protein Isoforms
Lung
lcsh:QH301-705.5
Spectroscopy
media_common
Organic cation transport proteins
biology
Chemistry
General Medicine
Computer Science Applications
medicine.anatomical_structure
Ergothioneine
Disease Susceptibility
pulmonary drug delivery
Drug
SLC22A1–5
Organic Cation Transport Proteins
media_common.quotation_subject
Respiratory Mucosa
Catalysis
Inorganic Chemistry
lung epithelium
03 medical and health sciences
Pharmacological Concepts
medicine
Animals
Humans
anticholinergics
Physical and Theoretical Chemistry
Molecular Biology
Organic Chemistry
Biological Transport
Transporter
Solute carrier family
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
biology.protein
chronic lung diseases
β2-agonists
Zdroj: International Journal of Molecular Sciences, Vol 21, Iss 9168, p 9168 (2020)
International Journal of Molecular Sciences
ISSN: 1661-6596
1422-0067
Popis: Organic cation transporters (OCT) 1, 2 and 3 and novel organic cation transporters (OCTN) 1 and 2 of the solute carrier 22 (SLC22) family are involved in the cellular transport of endogenous compounds such as neurotransmitters, l-carnitine and ergothioneine. OCT/Ns have also been implicated in the transport of xenobiotics across various biological barriers, for example biguanides and histamine receptor antagonists. In addition, several drugs used in the treatment of respiratory disorders are cations at physiological pH and potential substrates of OCT/Ns. OCT/Ns may also be associated with the development of chronic lung diseases such as allergic asthma and chronic obstructive pulmonary disease (COPD) and, thus, are possible new drug targets. As part of the Special Issue “Physiology, Biochemistry and Pharmacology of Transporters for Organic Cations”, this review provides an overview of recent findings on the (patho)physiological and pharmacological functions of organic cation transporters in the lung.
Databáze: OpenAIRE